Search Results for "Dry Eyes"
Search again or select article below to purchase. Single article price: $45. Order 3 or more at one time and receive a 10% discount.
Sort by relevance | Sort by date
Searched for Dry Eyes. Results 21 to 24 of 24 total matches.
Berdazimer Gel (Zelsuvmi) for Molluscum Contagiosum
The Medical Letter on Drugs and Therapeutics • Jun 04, 2024 (Issue 5073)
for up to 12 weeks. The gel should be allowed to dry
for 10 minutes after application. Swimming, bathing ...
Berdazimer 10.3% gel (Zelsuvmi – Ligand), a first-in-class
nitric oxide-releasing agent, has been approved
by the FDA for topical treatment of molluscum
contagiosum in patients ≥1 year old. It is the second
drug to become available in the US for treatment
of molluscum contagiosum and the first that can
be applied by the patient or caregiver at home;
cantharidin 0.7% solution (Ycanth), which is applied
by a healthcare professional, was approved earlier for
use in patients ≥2 years old.
Med Lett Drugs Ther. 2024 Jun 4;66(5073):1-2 doi:10.58347/tml.2024.5073a | Show Introduction Hide Introduction
Elafibranor (Iqirvo) for Primary Biliary Cholangitis
The Medical Letter on Drugs and Therapeutics • Dec 23, 2024 (Issue 1718)
Elafibranor: el” a fi b’ ra nor Iqirvo: eye ker vo
PPAR = peroxisome proliferator-activated receptor
PBC ...
Elafibranor (Iqirvo – Ipsen), a peroxisome proliferator-activated
receptor (PPAR) agonist, has been granted
accelerated approval by the FDA for treatment of
primary biliary cholangitis (PBC) in adults. It is
indicated for use in combination with ursodeoxycholic
acid (ursodiol, UDCA; Urso, and others) in patients
with an inadequate response to UDCA alone and as
monotherapy in those unable to tolerate UDCA.
Med Lett Drugs Ther. 2024 Dec 23;66(1718):202-4 doi:10.58347/tml.2024.1718b | Show Introduction Hide Introduction
Comparison Table: Some Lipid-Lowering Drugs (online only)
The Medical Letter on Drugs and Therapeutics • Sep 19, 2022 (Issue 1659)
of peptic
ulcers can occur
▶ Dry eyes and skin hyperpigmentation can occur rarely
▶ Flushing more common ...
View the Comparison Table: Some Lipid-Lowering Drugs
Lipid-Lowering Drugs
The Medical Letter on Drugs and Therapeutics • Sep 19, 2022 (Issue 1659)
, dry eyes
or skin hyperpigmentation. Some adverse effects,
particularly flushing, are more common ...
Cholesterol management guidelines from the
American College of Cardiology/American Heart
Association Task Force were last published in 2019.